nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—systemic scleroderma—ankylosing spondylitis	0.271	0.407	CtDrD
Mycophenolate mofetil—systemic lupus erythematosus—ankylosing spondylitis	0.221	0.331	CtDrD
Mycophenolate mofetil—psoriasis—ankylosing spondylitis	0.175	0.262	CtDrD
Mycophenolate mofetil—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0279	0.11	CbGbCtD
Mycophenolate mofetil—ABCC2—Sulfasalazine—ankylosing spondylitis	0.0245	0.0969	CbGbCtD
Mycophenolate mofetil—ABCG2—Sulfasalazine—ankylosing spondylitis	0.0222	0.0876	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Methotrexate—ankylosing spondylitis	0.0192	0.076	CbGbCtD
Mycophenolate mofetil—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0123	0.0486	CbGbCtD
Mycophenolate mofetil—ABCC2—Dexamethasone—ankylosing spondylitis	0.0122	0.0484	CbGbCtD
Mycophenolate mofetil—ALB—Prednisone—ankylosing spondylitis	0.0122	0.0483	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0112	0.0442	CbGbCtD
Mycophenolate mofetil—ABCG2—Dexamethasone—ankylosing spondylitis	0.0111	0.0437	CbGbCtD
Mycophenolate mofetil—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0105	0.0417	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—ankylosing spondylitis	0.00983	0.0389	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—ankylosing spondylitis	0.00889	0.0352	CbGbCtD
Mycophenolate mofetil—ABCB1—Betamethasone—ankylosing spondylitis	0.00685	0.0271	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisolone—ankylosing spondylitis	0.00676	0.0268	CbGbCtD
Mycophenolate mofetil—ABCB1—Prednisone—ankylosing spondylitis	0.00639	0.0253	CbGbCtD
Mycophenolate mofetil—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.00632	0.025	CbGbCtD
Mycophenolate mofetil—CYP3A5—Dexamethasone—ankylosing spondylitis	0.00613	0.0242	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—ankylosing spondylitis	0.00613	0.0242	CbGbCtD
Mycophenolate mofetil—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00589	0.0233	CbGbCtD
Mycophenolate mofetil—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00479	0.0189	CbGbCtD
Mycophenolate mofetil—CYP3A4—Betamethasone—ankylosing spondylitis	0.00411	0.0162	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisolone—ankylosing spondylitis	0.00405	0.016	CbGbCtD
Mycophenolate mofetil—ABCB1—Dexamethasone—ankylosing spondylitis	0.00399	0.0158	CbGbCtD
Mycophenolate mofetil—CYP3A4—Prednisone—ankylosing spondylitis	0.00383	0.0151	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—ankylosing spondylitis	0.0032	0.0127	CbGbCtD
Mycophenolate mofetil—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00239	0.00945	CbGbCtD
Mycophenolate mofetil—Syncope—Dexamethasone—ankylosing spondylitis	4.93e-05	0.000612	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Prednisone—ankylosing spondylitis	4.91e-05	0.00061	CcSEcCtD
Mycophenolate mofetil—Infection—Triamcinolone—ankylosing spondylitis	4.91e-05	0.00061	CcSEcCtD
Mycophenolate mofetil—Sweating—Methotrexate—ankylosing spondylitis	4.9e-05	0.00061	CcSEcCtD
Mycophenolate mofetil—Infection—Methylprednisolone—ankylosing spondylitis	4.9e-05	0.000609	CcSEcCtD
Mycophenolate mofetil—Haematuria—Methotrexate—ankylosing spondylitis	4.88e-05	0.000606	CcSEcCtD
Mycophenolate mofetil—Shock—Triamcinolone—ankylosing spondylitis	4.86e-05	0.000604	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisolone—ankylosing spondylitis	4.86e-05	0.000604	CcSEcCtD
Mycophenolate mofetil—Alopecia—Prednisone—ankylosing spondylitis	4.86e-05	0.000604	CcSEcCtD
Mycophenolate mofetil—Shock—Methylprednisolone—ankylosing spondylitis	4.85e-05	0.000603	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	4.84e-05	0.000602	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	4.83e-05	0.000601	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	4.83e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Betamethasone—ankylosing spondylitis	4.83e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Methotrexate—ankylosing spondylitis	4.82e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisolone—ankylosing spondylitis	4.82e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Triamcinolone—ankylosing spondylitis	4.82e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Prednisone—ankylosing spondylitis	4.81e-05	0.000599	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Methylprednisolone—ankylosing spondylitis	4.81e-05	0.000598	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methylprednisolone—ankylosing spondylitis	4.79e-05	0.000595	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Prednisone—ankylosing spondylitis	4.78e-05	0.000595	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	4.78e-05	0.000594	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—ankylosing spondylitis	4.77e-05	0.000594	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	4.76e-05	0.000592	CcSEcCtD
Mycophenolate mofetil—Convulsion—Betamethasone—ankylosing spondylitis	4.76e-05	0.000592	CcSEcCtD
Mycophenolate mofetil—Convulsion—Dexamethasone—ankylosing spondylitis	4.76e-05	0.000592	CcSEcCtD
Mycophenolate mofetil—Hypertension—Betamethasone—ankylosing spondylitis	4.74e-05	0.00059	CcSEcCtD
Mycophenolate mofetil—Hypertension—Dexamethasone—ankylosing spondylitis	4.74e-05	0.00059	CcSEcCtD
Mycophenolate mofetil—Myalgia—Dexamethasone—ankylosing spondylitis	4.68e-05	0.000581	CcSEcCtD
Mycophenolate mofetil—Myalgia—Betamethasone—ankylosing spondylitis	4.68e-05	0.000581	CcSEcCtD
Mycophenolate mofetil—Anxiety—Dexamethasone—ankylosing spondylitis	4.66e-05	0.000579	CcSEcCtD
Mycophenolate mofetil—Anxiety—Betamethasone—ankylosing spondylitis	4.66e-05	0.000579	CcSEcCtD
Mycophenolate mofetil—Discomfort—Dexamethasone—ankylosing spondylitis	4.62e-05	0.000574	CcSEcCtD
Mycophenolate mofetil—Discomfort—Betamethasone—ankylosing spondylitis	4.62e-05	0.000574	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Methotrexate—ankylosing spondylitis	4.62e-05	0.000574	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methylprednisolone—ankylosing spondylitis	4.61e-05	0.000573	CcSEcCtD
Mycophenolate mofetil—Pain—Prednisolone—ankylosing spondylitis	4.59e-05	0.000571	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—ankylosing spondylitis	4.59e-05	0.000571	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—ankylosing spondylitis	4.59e-05	0.000571	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Methotrexate—ankylosing spondylitis	4.56e-05	0.000567	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—ankylosing spondylitis	4.53e-05	0.000564	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Methotrexate—ankylosing spondylitis	4.5e-05	0.00056	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	4.5e-05	0.00056	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	4.49e-05	0.000558	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	4.48e-05	0.000557	CcSEcCtD
Mycophenolate mofetil—Oedema—Dexamethasone—ankylosing spondylitis	4.48e-05	0.000557	CcSEcCtD
Mycophenolate mofetil—Oedema—Betamethasone—ankylosing spondylitis	4.48e-05	0.000557	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Betamethasone—ankylosing spondylitis	4.48e-05	0.000557	CcSEcCtD
Mycophenolate mofetil—Insomnia—Triamcinolone—ankylosing spondylitis	4.47e-05	0.000556	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methylprednisolone—ankylosing spondylitis	4.46e-05	0.000554	CcSEcCtD
Mycophenolate mofetil—Infection—Dexamethasone—ankylosing spondylitis	4.45e-05	0.000554	CcSEcCtD
Mycophenolate mofetil—Infection—Betamethasone—ankylosing spondylitis	4.45e-05	0.000554	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Prednisone—ankylosing spondylitis	4.44e-05	0.000552	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Triamcinolone—ankylosing spondylitis	4.44e-05	0.000552	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisolone—ankylosing spondylitis	4.43e-05	0.00055	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	4.43e-05	0.00055	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—ankylosing spondylitis	4.43e-05	0.00055	CcSEcCtD
Mycophenolate mofetil—Anaemia—Prednisone—ankylosing spondylitis	4.42e-05	0.00055	CcSEcCtD
Mycophenolate mofetil—Shock—Dexamethasone—ankylosing spondylitis	4.41e-05	0.000548	CcSEcCtD
Mycophenolate mofetil—Shock—Betamethasone—ankylosing spondylitis	4.41e-05	0.000548	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Triamcinolone—ankylosing spondylitis	4.4e-05	0.000548	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Dexamethasone—ankylosing spondylitis	4.4e-05	0.000547	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Betamethasone—ankylosing spondylitis	4.4e-05	0.000547	CcSEcCtD
Mycophenolate mofetil—Agitation—Prednisone—ankylosing spondylitis	4.4e-05	0.000547	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	4.39e-05	0.000546	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Betamethasone—ankylosing spondylitis	4.39e-05	0.000546	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Betamethasone—ankylosing spondylitis	4.37e-05	0.000544	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Dexamethasone—ankylosing spondylitis	4.37e-05	0.000544	CcSEcCtD
Mycophenolate mofetil—Angioedema—Prednisone—ankylosing spondylitis	4.37e-05	0.000543	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Triamcinolone—ankylosing spondylitis	4.35e-05	0.000541	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	4.34e-05	0.00054	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	4.33e-05	0.000539	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Betamethasone—ankylosing spondylitis	4.33e-05	0.000539	CcSEcCtD
Mycophenolate mofetil—Malaise—Prednisone—ankylosing spondylitis	4.31e-05	0.000536	CcSEcCtD
Mycophenolate mofetil—Vertigo—Prednisone—ankylosing spondylitis	4.3e-05	0.000534	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—ankylosing spondylitis	4.29e-05	0.000534	CcSEcCtD
Mycophenolate mofetil—Syncope—Prednisone—ankylosing spondylitis	4.29e-05	0.000533	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—ankylosing spondylitis	4.28e-05	0.000532	CcSEcCtD
Mycophenolate mofetil—Anorexia—Dexamethasone—ankylosing spondylitis	4.27e-05	0.000531	CcSEcCtD
Mycophenolate mofetil—Anorexia—Betamethasone—ankylosing spondylitis	4.27e-05	0.000531	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisolone—ankylosing spondylitis	4.27e-05	0.000531	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—ankylosing spondylitis	4.26e-05	0.00053	CcSEcCtD
Mycophenolate mofetil—Pain—Triamcinolone—ankylosing spondylitis	4.22e-05	0.000525	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Prednisone—ankylosing spondylitis	4.2e-05	0.000523	CcSEcCtD
Mycophenolate mofetil—Hypotension—Dexamethasone—ankylosing spondylitis	4.19e-05	0.000521	CcSEcCtD
Mycophenolate mofetil—Hypotension—Betamethasone—ankylosing spondylitis	4.19e-05	0.000521	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—ankylosing spondylitis	4.17e-05	0.000518	CcSEcCtD
Mycophenolate mofetil—Convulsion—Prednisone—ankylosing spondylitis	4.14e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—ankylosing spondylitis	4.14e-05	0.000515	CcSEcCtD
Mycophenolate mofetil—Hypertension—Prednisone—ankylosing spondylitis	4.13e-05	0.000513	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—ankylosing spondylitis	4.12e-05	0.000512	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	4.08e-05	0.000508	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	4.08e-05	0.000508	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Prednisone—ankylosing spondylitis	4.07e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Myalgia—Prednisone—ankylosing spondylitis	4.07e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Triamcinolone—ankylosing spondylitis	4.07e-05	0.000506	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	4.06e-05	0.000505	CcSEcCtD
Mycophenolate mofetil—Anxiety—Prednisone—ankylosing spondylitis	4.06e-05	0.000505	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—ankylosing spondylitis	4.06e-05	0.000505	CcSEcCtD
Mycophenolate mofetil—Insomnia—Dexamethasone—ankylosing spondylitis	4.05e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Insomnia—Betamethasone—ankylosing spondylitis	4.05e-05	0.000504	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	4.04e-05	0.000503	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	4.03e-05	0.000501	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Dexamethasone—ankylosing spondylitis	4.02e-05	0.0005	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Betamethasone—ankylosing spondylitis	4.02e-05	0.0005	CcSEcCtD
Mycophenolate mofetil—Discomfort—Prednisone—ankylosing spondylitis	4.02e-05	0.0005	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—ankylosing spondylitis	4.02e-05	0.0005	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—ankylosing spondylitis	4e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisolone—ankylosing spondylitis	3.96e-05	0.000492	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Betamethasone—ankylosing spondylitis	3.95e-05	0.000491	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Dexamethasone—ankylosing spondylitis	3.95e-05	0.000491	CcSEcCtD
Mycophenolate mofetil—Urticaria—Triamcinolone—ankylosing spondylitis	3.92e-05	0.000488	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methylprednisolone—ankylosing spondylitis	3.92e-05	0.000487	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—ankylosing spondylitis	3.91e-05	0.000487	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Triamcinolone—ankylosing spondylitis	3.91e-05	0.000486	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Prednisone—ankylosing spondylitis	3.9e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Oedema—Prednisone—ankylosing spondylitis	3.9e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	3.9e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Dexamethasone—ankylosing spondylitis	3.9e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Betamethasone—ankylosing spondylitis	3.9e-05	0.000485	CcSEcCtD
Mycophenolate mofetil—Infection—Prednisone—ankylosing spondylitis	3.88e-05	0.000482	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	3.87e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	3.87e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—ankylosing spondylitis	3.87e-05	0.000481	CcSEcCtD
Mycophenolate mofetil—Shock—Prednisone—ankylosing spondylitis	3.84e-05	0.000478	CcSEcCtD
Mycophenolate mofetil—Pain—Dexamethasone—ankylosing spondylitis	3.83e-05	0.000477	CcSEcCtD
Mycophenolate mofetil—Pain—Betamethasone—ankylosing spondylitis	3.83e-05	0.000477	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Prednisone—ankylosing spondylitis	3.83e-05	0.000476	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Prednisone—ankylosing spondylitis	3.81e-05	0.000474	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Prednisone—ankylosing spondylitis	3.79e-05	0.000471	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Prednisone—ankylosing spondylitis	3.77e-05	0.000469	CcSEcCtD
Mycophenolate mofetil—Anorexia—Prednisone—ankylosing spondylitis	3.72e-05	0.000463	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—ankylosing spondylitis	3.71e-05	0.000461	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—ankylosing spondylitis	3.69e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Dexamethasone—ankylosing spondylitis	3.69e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Betamethasone—ankylosing spondylitis	3.69e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	3.67e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	3.67e-05	0.000456	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Triamcinolone—ankylosing spondylitis	3.64e-05	0.000453	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	3.63e-05	0.000452	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—ankylosing spondylitis	3.6e-05	0.000448	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—ankylosing spondylitis	3.59e-05	0.000447	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—ankylosing spondylitis	3.58e-05	0.000445	CcSEcCtD
Mycophenolate mofetil—Urticaria—Betamethasone—ankylosing spondylitis	3.56e-05	0.000443	CcSEcCtD
Mycophenolate mofetil—Urticaria—Dexamethasone—ankylosing spondylitis	3.56e-05	0.000443	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	3.56e-05	0.000442	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisolone—ankylosing spondylitis	3.55e-05	0.000442	CcSEcCtD
Mycophenolate mofetil—Asthenia—Triamcinolone—ankylosing spondylitis	3.54e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Betamethasone—ankylosing spondylitis	3.54e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Dexamethasone—ankylosing spondylitis	3.54e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Dexamethasone—ankylosing spondylitis	3.54e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Betamethasone—ankylosing spondylitis	3.54e-05	0.000441	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methylprednisolone—ankylosing spondylitis	3.54e-05	0.00044	CcSEcCtD
Mycophenolate mofetil—Insomnia—Prednisone—ankylosing spondylitis	3.53e-05	0.000439	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Prednisone—ankylosing spondylitis	3.51e-05	0.000436	CcSEcCtD
Mycophenolate mofetil—Pruritus—Triamcinolone—ankylosing spondylitis	3.5e-05	0.000435	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—ankylosing spondylitis	3.49e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methylprednisolone—ankylosing spondylitis	3.49e-05	0.000434	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—ankylosing spondylitis	3.46e-05	0.000431	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Prednisone—ankylosing spondylitis	3.44e-05	0.000427	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—ankylosing spondylitis	3.4e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—ankylosing spondylitis	3.4e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—ankylosing spondylitis	3.4e-05	0.000423	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Prednisone—ankylosing spondylitis	3.39e-05	0.000422	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisolone—ankylosing spondylitis	3.39e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisolone—ankylosing spondylitis	3.38e-05	0.000421	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	3.38e-05	0.00042	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	3.37e-05	0.000419	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisolone—ankylosing spondylitis	3.37e-05	0.000418	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—ankylosing spondylitis	3.36e-05	0.000418	CcSEcCtD
Mycophenolate mofetil—Constipation—Prednisone—ankylosing spondylitis	3.34e-05	0.000415	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—ankylosing spondylitis	3.29e-05	0.000409	CcSEcCtD
Mycophenolate mofetil—Dizziness—Triamcinolone—ankylosing spondylitis	3.27e-05	0.000406	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—ankylosing spondylitis	3.26e-05	0.000406	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methylprednisolone—ankylosing spondylitis	3.26e-05	0.000405	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—ankylosing spondylitis	3.24e-05	0.000403	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Prednisone—ankylosing spondylitis	3.22e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Asthenia—Dexamethasone—ankylosing spondylitis	3.22e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Asthenia—Betamethasone—ankylosing spondylitis	3.22e-05	0.0004	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—ankylosing spondylitis	3.2e-05	0.000398	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—ankylosing spondylitis	3.19e-05	0.000397	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	3.19e-05	0.000397	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisolone—ankylosing spondylitis	3.19e-05	0.000397	CcSEcCtD
Mycophenolate mofetil—Pruritus—Dexamethasone—ankylosing spondylitis	3.17e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Pruritus—Betamethasone—ankylosing spondylitis	3.17e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—ankylosing spondylitis	3.17e-05	0.000394	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—ankylosing spondylitis	3.15e-05	0.000392	CcSEcCtD
Mycophenolate mofetil—Vomiting—Triamcinolone—ankylosing spondylitis	3.14e-05	0.000391	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methylprednisolone—ankylosing spondylitis	3.13e-05	0.00039	CcSEcCtD
Mycophenolate mofetil—Rash—Triamcinolone—ankylosing spondylitis	3.11e-05	0.000387	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Triamcinolone—ankylosing spondylitis	3.11e-05	0.000387	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—ankylosing spondylitis	3.11e-05	0.000387	CcSEcCtD
Mycophenolate mofetil—Rash—Methylprednisolone—ankylosing spondylitis	3.11e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methylprednisolone—ankylosing spondylitis	3.1e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Urticaria—Prednisone—ankylosing spondylitis	3.1e-05	0.000386	CcSEcCtD
Mycophenolate mofetil—Headache—Triamcinolone—ankylosing spondylitis	3.09e-05	0.000385	CcSEcCtD
Mycophenolate mofetil—Headache—Methylprednisolone—ankylosing spondylitis	3.09e-05	0.000384	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Prednisone—ankylosing spondylitis	3.09e-05	0.000384	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Prednisone—ankylosing spondylitis	3.09e-05	0.000384	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Betamethasone—ankylosing spondylitis	3.07e-05	0.000381	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dexamethasone—ankylosing spondylitis	3.07e-05	0.000381	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—ankylosing spondylitis	3.05e-05	0.000379	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	2.97e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—Dizziness—Dexamethasone—ankylosing spondylitis	2.96e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Dizziness—Betamethasone—ankylosing spondylitis	2.96e-05	0.000369	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—ankylosing spondylitis	2.95e-05	0.000367	CcSEcCtD
Mycophenolate mofetil—Nausea—Triamcinolone—ankylosing spondylitis	2.93e-05	0.000365	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—ankylosing spondylitis	2.93e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Nausea—Methylprednisolone—ankylosing spondylitis	2.93e-05	0.000364	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—ankylosing spondylitis	2.91e-05	0.000362	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—ankylosing spondylitis	2.9e-05	0.000361	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Prednisone—ankylosing spondylitis	2.88e-05	0.000358	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—ankylosing spondylitis	2.87e-05	0.000357	CcSEcCtD
Mycophenolate mofetil—Vomiting—Betamethasone—ankylosing spondylitis	2.85e-05	0.000354	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dexamethasone—ankylosing spondylitis	2.85e-05	0.000354	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—ankylosing spondylitis	2.84e-05	0.000353	CcSEcCtD
Mycophenolate mofetil—Rash—Betamethasone—ankylosing spondylitis	2.83e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Rash—Dexamethasone—ankylosing spondylitis	2.83e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Dexamethasone—ankylosing spondylitis	2.82e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Betamethasone—ankylosing spondylitis	2.82e-05	0.000351	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	2.82e-05	0.00035	CcSEcCtD
Mycophenolate mofetil—Headache—Betamethasone—ankylosing spondylitis	2.81e-05	0.000349	CcSEcCtD
Mycophenolate mofetil—Headache—Dexamethasone—ankylosing spondylitis	2.81e-05	0.000349	CcSEcCtD
Mycophenolate mofetil—Asthenia—Prednisone—ankylosing spondylitis	2.8e-05	0.000348	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—ankylosing spondylitis	2.79e-05	0.000347	CcSEcCtD
Mycophenolate mofetil—Pruritus—Prednisone—ankylosing spondylitis	2.76e-05	0.000343	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—ankylosing spondylitis	2.69e-05	0.000334	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Prednisone—ankylosing spondylitis	2.67e-05	0.000332	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	2.67e-05	0.000332	CcSEcCtD
Mycophenolate mofetil—Nausea—Dexamethasone—ankylosing spondylitis	2.66e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Nausea—Betamethasone—ankylosing spondylitis	2.66e-05	0.000331	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—ankylosing spondylitis	2.59e-05	0.000322	CcSEcCtD
Mycophenolate mofetil—Dizziness—Prednisone—ankylosing spondylitis	2.58e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—ankylosing spondylitis	2.58e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—ankylosing spondylitis	2.58e-05	0.000321	CcSEcCtD
Mycophenolate mofetil—Vomiting—Prednisone—ankylosing spondylitis	2.48e-05	0.000309	CcSEcCtD
Mycophenolate mofetil—Rash—Prednisone—ankylosing spondylitis	2.46e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Prednisone—ankylosing spondylitis	2.46e-05	0.000306	CcSEcCtD
Mycophenolate mofetil—Headache—Prednisone—ankylosing spondylitis	2.45e-05	0.000304	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—ankylosing spondylitis	2.4e-05	0.000299	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methotrexate—ankylosing spondylitis	2.34e-05	0.000291	CcSEcCtD
Mycophenolate mofetil—Nausea—Prednisone—ankylosing spondylitis	2.32e-05	0.000288	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—ankylosing spondylitis	2.31e-05	0.000287	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—ankylosing spondylitis	2.23e-05	0.000278	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—ankylosing spondylitis	2.16e-05	0.000268	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methotrexate—ankylosing spondylitis	2.07e-05	0.000258	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—ankylosing spondylitis	2.06e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—ankylosing spondylitis	2.06e-05	0.000256	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—ankylosing spondylitis	2.04e-05	0.000254	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—ankylosing spondylitis	1.94e-05	0.000241	CcSEcCtD
